首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1441245

全球市场规模、份额、成长分析（按产品、按应用） - 产业预测，2023-2030 年

Global Lacrimal Devices Market Size, Share, Growth Analysis, By Product(Intubation Sets, Stents And Tubes), By Application(Glaucoma, Dry Eye) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球泪器官市场规模为2001.6亿美元，从2023年的2171.7亿美元增长到2031年的4171.1亿美元，预测期内（2024-2031年）复合年增长率为8.5%，预计将增长至100万美元。

由于不同年龄层对眼部疾病的认识和诊断不断提高，泪器官市场正在显着增长。

随着眼部疾病的增加，对先进泪道装置（如穿刺塞、泪道支架和冲洗系统）的需求不断增加。此外，技术和手术方法的进步正在改善患者的治疗效果并有助于市场的扩张。人口老化以及与老龄化相关的眼睛问题的相应增加也促进了市场的持续增长。医疗保健提供者和製造商正在积极致力于开发创新解决方案，以满足泪液障碍患者不断变化的需求，重点是提高护理品质和患者舒适度。监管因素和报销政策在塑造市场动态方面也发挥着重要作用。总体而言，泪道装置市场为眼科装置领域的公司提供了充满希望的机会，越来越注重以患者为中心的解决方案和改善治疗结果。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

FCI 眼科（法国）
钟化株式会社（日本）
Lacrimedics, Inc.（美国）
库克集团（美国）
英属维京群岛（英国）
Rumex 国际（美国）
贝斯医疗技术有限公司（德国）
爱尔康（瑞士）
博士伦公司（美国）
BraunMelsungen AG（德国）
绿洲医疗公司（美国）
Beaver-Visitec International（美国）
FC光学有限公司（以色列）
DORC 荷兰眼科研究中心（荷兰）
OptiMedica 公司（美国）
显微外科技术（美国）
Diamatrix 有限公司（英国）
FCI SAS（法国）
诺华公司（瑞士）
Eye Kon Medical, Inc.（美国）

简介目录

Product Code: SQMIG35G2212

Global Lacrimal Devices Market size was valued at USD 200.16 Billion in 2022 and is poised to grow from USD 217.17 Billion in 2023 to USD Billion 417.11 by 2031, at a CAGR of 8.5% during the forecast period (2024-2031).

The lacrimal devices market is experiencing substantial growth due to the rising awareness and diagnosis of ophthalmic conditions across various age demographics.

With an increase in eye-related disorders, there is a growing demand for advanced lacrimal devices such as punctual plugs, lacrimal stents, and irrigation systems. Furthermore, advancements in technology and surgical methods have resulted in better patient outcomes, contributing to the expansion of the market. The aging population and the corresponding rise in age-related eye issues also contribute to the market's sustained growth. Healthcare providers and manufacturers are actively working on developing innovative solutions to meet the evolving needs of patients with lacrimal disorders, with a focus on improving care quality and patient comfort. Regulatory factors and reimbursement policies also play a significant role in shaping the market's dynamics. Overall, the lacrimal devices market presents promising opportunities for companies in the ophthalmic devices sector, with an increasing emphasis on patient-centred solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lacrimal Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lacrimal Devices Market Segmental Analysis

The global lacrimal devices market is segmented on the basis of product, application and region. Based on product the market is segmented as intubation sets, stents and tubes, dilators. On the basis of application, the market is segmented as glaucoma, dry eye, and lacrimal gland inflammation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Lacrimal Devices Market

The main factor fuelling the lacrimal devices market is the rising prevalence of eye disorders worldwide. Elements such as aging populations, shifting lifestyles, and increased screen usage lead to conditions such as dry eye syndrome and other lacrimal system disorders. This results in an increased need for lacrimal devices for diagnosing and treating these conditions, driving the growth of the market.

Restraints in the Global Lacrimal Devices Market

A significant challenge in the lacrimal devices sector is the strict regulatory environment and potential delays in obtaining approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, have rigorous standards for medical devices, which can result in prolonged timelines for market introduction. These regulatory obstacles can hinder innovation and market expansion, affecting both established companies and new entrants in the field.

Market Trends of the Global Lacrimal Devices Market

A notable trend in the lacrimal devices market is the growing inclination towards minimally invasive procedures. Patients and healthcare providers are favouring less invasive methods for treating lacrimal system disorders due to their advantages, including faster recovery times, fewer postoperative complications, and enhanced patient comfort. This shift is spurring innovation in the creation of minimally invasive lacrimal devices, such as micro endoscopes and specialized catheters, to meet the changing preferences in patient care.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Lacrimal Devices Market by Product

Market Overview
Intubation Sets
Stents And Tubes
Dilators

Global Lacrimal Devices Market by Application

Market Overview
Glaucoma
Dry Eye
Lacrimal Gland Inflammation

Global Lacrimal Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

FCI Ophthalmic (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lacrimedics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BVI (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rumex International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bess Medical Technology GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch and Lomb Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BraunMelsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OASIS Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beaver-Visitec International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FC Optics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMedica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroSurgical Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diamatrix Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FCI S.A.S. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eye Kon Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments